Plain-English translation of NCT06804057 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term tracking study for people with systemic lupus erythematosus (SLE). Researchers will collect information about your lupus, the medications you take, and how you're doing over time. The goal is to understand how well current treatments work and whether they are safe when used in real-world practice.
Doctors need better information about how lupus medications perform over the long term in everyday patients. This study will help pharmaceutical companies, regulators, and healthcare providers make better decisions about which treatments work best and which side effects to watch for.
You likely qualify if…
You likely don't qualify if…
You will be part of a registry where researchers collect information about your lupus diagnosis, medications, and health over time. This involves sharing your medical records, completing surveys about how you feel, and allowing doctors to track your disease and any side effects. The study uses standardized questions and validated health surveys to gather consistent information from all participants.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States
Enrollment target
~1,000 participants
Started
September 2024
Primary completion
December 2099
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
CorEvitas, LLC
CorEvitas
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.